Atlas Trials

The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics

Clinical trial NCT03151707 · TERMINATED

Trial details

NCT number
NCT03151707
Sponsor
Mclean Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Healthy
Start date
2017-10-01
Primary completion
2022-09-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.